BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu XN, Deng Y, Zhang GC, Liu J, Liu TT, Dong L, Zhu CF, Shen XZ, Li YH, Zhu JM. Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. ACS Appl Mater Interfaces 2020;12:17193-206. [PMID: 32207914 DOI: 10.1021/acsami.0c00375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang S, Cai C, Wang H, Ma X, Shao A, Sheng J, Yu C. Drug delivery strategy in hepatocellular carcinoma therapy. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-021-00796-x] [Reference Citation Analysis]
2 Wen Z, Feng Y, Hu Y, Lian L, Huang H, Guo L, Chen S, Yang Q, Zhang M, Wan L, Xu K, Degejirifu, Yan X. Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer. Aging (Albany NY) 2021;13:1872-82. [PMID: 33440348 DOI: 10.18632/aging.103905] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zheng B, He Q, Li X, Yoon J, Huang J. Phthalocyanines as contrast agents for photothermal therapy. Coordination Chemistry Reviews 2021;426:213548. [DOI: 10.1016/j.ccr.2020.213548] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 26.0] [Reference Citation Analysis]
4 Gholizadeh M, Doustvandi MA, Mohammadnejad F, Shadbad MA, Tajalli H, Brunetti O, Argentiero A, Silvestris N, Baradaran B. Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers? Molecules 2021;26:6877. [PMID: 34833970 DOI: 10.3390/molecules26226877] [Reference Citation Analysis]
5 Cai X, Ding S, Shi Q, Lyu Z, Liu D, Dong WJ, Du M, Dutta P, Song Y, Du D, Lin Y. Eyeball-Like Yolk-Shell Bimetallic Nanoparticles for Synergistic Photodynamic-Photothermal Therapy. ACS Appl Bio Mater 2020;3:5922-9. [PMID: 35021820 DOI: 10.1021/acsabm.0c00624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
6 Du Y, Liu D, Du Y. Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment. J Drug Target 2021;:1-15. [PMID: 34727794 DOI: 10.1080/1061186X.2021.1999963] [Reference Citation Analysis]
7 Gourdon L, Cariou K, Gasser G. Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review. Chem Soc Rev 2022. [PMID: 35048929 DOI: 10.1039/d1cs00609f] [Reference Citation Analysis]
8 Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW. Engineering nanotheranostic strategies for liver cancer. World J Gastrointest Oncol 2021; 13(10): 1213-1228 [PMID: 34721763 DOI: 10.4251/wjgo.v13.i10.1213] [Reference Citation Analysis]
9 AbdElhamid AS, Zayed DG, Heikal L, Khattab SN, Mady OY, El-Gizawy SA, Elzoghby AO. Recent advances in polymer shell oily-core nanocapsules for drug-delivery applications. Nanomedicine (Lond) 2021;16:1613-25. [PMID: 34189946 DOI: 10.2217/nnm-2021-0037] [Reference Citation Analysis]
10 Zhu F, Wang BR, Zhu ZF, Wang SQ, Chai CX, Shang D, Li M. Photodynamic therapy: A next alternative treatment strategy for hepatocellular carcinoma? World J Gastrointest Surg 2021; 13(12): 1523-1535 [DOI: 10.4240/wjgs.v13.i12.1523] [Reference Citation Analysis]
11 Wu D, Zhang G, Ma J, Wu H, Xiong J, Huang X, Tian Y, Deng T, Han X, Sun X, Xiang T, Yu X, Jiang X. Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma. J Oncol 2021;2021:1301671. [PMID: 34659404 DOI: 10.1155/2021/1301671] [Reference Citation Analysis]
12 He L, Zhang Y, Chen J, Liu G, Zhu J, Li X, Li D, Yang Y, Lee CS, Shi J, Yin C, Lai P, Wang L, Fang C. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma. J Mater Chem B 2021;9:8779-92. [PMID: 34635903 DOI: 10.1039/d1tb01729b] [Reference Citation Analysis]
13 Wang K, Wang C, Jiang H, Zhang Y, Lin W, Mo J, Jin C. Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go. Front Immunol 2021;12:792781. [PMID: 34975896 DOI: 10.3389/fimmu.2021.792781] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Shi X, Liu TT, Yu XN, Balakrishnan A, Zhu HR, Guo HY, Zhang GC, Bilegsaikhan E, Sun JL, Song GQ, Weng SQ, Dong L, Ott M, Zhu JM, Shen XZ. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Oncogene 2020;39:5768-81. [PMID: 32719439 DOI: 10.1038/s41388-020-01401-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Russo E, Spallarossa A, Tasso B, Villa C, Brullo C. Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective. Int J Mol Sci 2021;22:6538. [PMID: 34207175 DOI: 10.3390/ijms22126538] [Reference Citation Analysis]
16 Yue H, Gou L, Tang Z, Liu Y, Liu S, Tang H. Construction of pH-responsive nanocarriers in combination with ferroptosis and chemotherapy for treatment of hepatocellular carcinoma. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00111-4] [Reference Citation Analysis]
17 Jiang X, Luo Z, Zhang B, Li P, Xiao J, Su W. Moderate microwave-assisted preparation of phthalocyanine-based carbon quantum dots for improved photo-inactivation of bacteria. Inorganic Chemistry Communications 2022;142:109543. [DOI: 10.1016/j.inoche.2022.109543] [Reference Citation Analysis]
18 Kong FH, Ye QF, Miao XY, Liu X, Huang SQ, Xiong L, Wen Y, Zhang ZJ. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics 2021;11:5464-90. [PMID: 33859758 DOI: 10.7150/thno.54822] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]